Catheter Precision (VTAK) Stock Analysis & Winston Score

Catheter Precision makes small medical devices used by doctors during heart procedures. Its products help physicians precisely position and control catheters — thin tubes inserted into the body — during cardiac electrophysiology treatments, which are procedures that fix abnormal heart rhythms. The company sells its tools to hospitals and cardiac catheterization labs across the United States. The company earns revenue by selling its devices directly to healthcare facilities, with no subscription model involved. It operates primarily in the U.S. and is a very small player in the medical device space, competing against much larger companies like Abbott and Biosig Technologies. Its gross margin is solid at around 56%, but its operating losses are severe, meaning it spends far more running the business than it brings in from sales — the biggest risk it faces is running out of cash before it can grow revenue enough to become profitable.